Skip to main content
Tuesday, November 17, 2026Nov 17

Stopping MS: Woman says experimental drug worked for her, so why didn’t the FDA approve it?

stopping-mswoman-says-experimental-drug-worked
stopping-mswoman-says-experimental-drug-worked
photo Katy Mena is an MS patient who was part of the clinical trials for a drug called Lemtrada.

ABOUT MSMultiple sclerosis is an autoimmune disease that tends to strike young people, usually between their 20s and 50s, with unpredictable and often disabling symptoms. The immune system attacks the coating around nerve fibers, hampering the system’s ability to communicate — resulting in symptoms ranging from blindness to fatigue to paralysis.The progress, severity and specific symptoms of MS in any one person cannot yet be predicted. Though symptoms may not be permanent, each relapse leaves the body worse off.At least two to three times more women are diagnosed with the disease than men. MS affects more than 2.3 million people worldwide.Source: National Multiple Sclerosis Society

The strange pains would attack without warning, almost as if they were changing with the weather.

And every time they hit Katy Mena – a young twentysomething, seemingly in her prime – it was something different. An unshakable cold in her legs. Double vision. Tingling pain in her limbs. A tight, squeezing sensation around her torso, like an unwelcome hug.

Sometimes a leg would go limp, or she suddenly couldn’t use her arm. Some days she would feel electric shocks all over her body.

For nearly a decade, Mena, now 32, battled the progression of multiple sclerosis with treatments that couldn’t seem to do much to keep its devastating effects at bay.